RA
DXCM icon

Riverstone Advisors’s DexCom DXCM Stock Holding History

Riverstone Advisors’s Portfolio DXCM Stock Details DXCM Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q4 		– Sell
-4,815
Closed -$324K – 60
2025
Q3 		$324K Sell
4,815
-3,379
-41% -$267K 0.16% 45
2025
Q2 		$715K Sell
8,194
-2,650
-24% -$208K 0.39% 27
2025
Q1 		$741K Sell
10,844
-5,721
-35% -$467K 0.45% 26
2024
Q4 		$1.29M Sell
16,565
-2,687
-14% -$199K 0.73% 20
2024
Q3 		$1.29M Sell
19,252
-2,566
-12% -$211K 0.75% 19
2024
Q2 		$2.47M Sell
21,818
-23,160
-51% -$2.93M 1.52% 15
2024
Q1 		$6.24M Sell
44,978
-2,260
-5% -$284K 3.72% 8
2023
Q4 		$5.86M Sell
47,238
-3,032
-6% -$310K 3.79% 9
2023
Q3 		$4.69M Sell
50,270
-976
-2% -$110K 3.24% 10
2023
Q2 		$6.59M Sell
51,246
-766
-1% -$92.6K 4% 10
2023
Q1 		$6.04M Buy
52,012
+2,098
+4% +$235K 3.86% 11
2022
Q4 		$5.65M Sell
49,914
-718
-1% -$78.8K 3.92% 11
2022
Q3 		$4.08M Sell
50,632
-4,884
-9% -$414K 2.63% 11
2022
Q2 		$4.14M Buy
55,516
+28
+0.1% +$2.56K 2.6% 12
2022
Q1 		$7.1M Sell
55,488
-264
-0.5% -$28.9K 3.64% 12
2021
Q4 		$7.48M Buy
55,752
+1,320
+2% +$190K 3.29% 12
2021
Q3 		$7.44M Buy
54,432
+1,316
+2% +$166K 3.43% 11
2021
Q2 		$5.67M Buy
53,116
+512
+1% +$49.2K 2.68% 14
2021
Q1 		$4.73M Buy
52,604
+3,540
+7% +$332K 2.47% 14
2020
Q4 		$4.54M Buy
49,064
+26,164
+114% +$2.34M 2.52% 13
2020
Q3 		$2.36M Buy
22,900
+4,624
+25% +$483K 1.57% 17
2020
Q2 		$1.85M Buy
+18,276
New +$1.63M 1.38% 17

Other funds holding DXCM

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Baillie Gifford & Co
Baillie Gifford & Co Edinburgh, United Kingdom $110B AUM 4.8% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
AllianceBernstein
AllianceBernstein Nashville, Tennessee $302B AUM 26.44% 1-Year Est. Return
UBS AM
UBS AM Chicago, Illinois $550B AUM 43.33% 1-Year Est. Return
Norges Bank
Norges Bank Oslo, Norway $1T AUM
JP Morgan Chase
JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return

Riverstone Advisors's DXCM Position: Q4 2025 in Review

Riverstone Advisors sold out of DexCom (DXCM) in Q4 2025, closing a stake of 4,815 shares — an estimated $324K sold.

Riverstone Advisors first reported a position in DXCM in Q2 2020 and held it in 22 quarters. The position peaked at $7.48M in Q4 2021. 922 funds tracked by Wall St. Rank hold DXCM as of Q4 2025.

  • Riverstone Advisors reported no remaining DexCom position as of Q4 2025 after selling out during the quarter.
  • Riverstone Advisors sold 4,815 DexCom shares in Q4 2025, an estimated $324K.
  • Riverstone Advisors first reported a position in DexCom in Q2 2020 and held it in 22 quarters.
  • Riverstone Advisors's DexCom position peaked at $7.48M in Q4 2021.
  • 922 funds tracked by Wall St. Rank held DexCom as of Q4 2025.

Based on Riverstone Advisors's 13F filing for Q4 2025, filed 2 Feb 2026.